I reiterate my buy rating on Workday as AI monetization is now a tangible revenue driver, with new ACV tied to AI more than doubling year-over-year. The partner ecosystem flywheel is accelerating, ...
Company remains on track for first subject treated in pivotal, adaptive Phase 3 clinical trial (the "MIRACLE" trial) in the first quarter of 2025 Mr. Klemp added, "The spirit of collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback